Erschienen in:
06.09.2022 | Case report
Systemic chemotherapy for unresectable or recurrent primary thymic adenocarcinoma of enteric type
verfasst von:
Xiaofang Gao
Erschienen in:
International Cancer Conference Journal
|
Ausgabe 1/2023
Einloggen, um Zugang zu erhalten
Abstract
Primary thymic adenocarcinoma of enteric type is a very rare subtype of thymic carcinoma. Choosing appropriate systemic chemotherapy for patients with unresectable or recurrent disease remain a big challenge. We present a case of 38-year-old man with primary thymic adenocarcinoma of enteric type. The patient received multiline chemotherapy. Metastatic lesions were effectively controlled by FOLFOX (oxaliplatin/5-fluorouracil/leucovorin) chemotherapy. According to the present case and the literature review, FOLFOX and XELOX (capecitabine/oxaliplatin) regimens are reasonable treatment choice for unresectable or recurrent primary thymic adenocarcinoma of enteric type, even in the first-line chemotherapy.